American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cell line-specific network models of ER(+) breast cancer identify potential PI3Kα inhibitor resistance mechanisms and drug combinations
    Journal Article

    Zañudo, J. G. T.; Mao, P.; Alcon, C.; Kowalski, K.; Johnson, G. N.; Xu, G.; Baselga, J.; Scaltriti, M.; Letai, A.; Montero, J.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Quantitative in vivo analyses reveal a complex pharmacogenomic landscape in lung adenocarcinoma
    Journal Article

    Li, C.; Lin, W. Y.; Rizvi, H.; Cai, H.; McFarland, C. D.; Rogers, Z. N.; Yousefi, M.; Winters, I. P.; Rudin, C. M.; Petrov, D. A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • CHRONOS-3: Randomized Phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Matasar, M. J.; Capra, M.; Özcan, M.; Lv, F.; Li, W.; Yañez, E.; Sapunarova, K.; Lin, T.; Jin, J.; Jurczak, W.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase 1/2 study of a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), BDC-1001, alone and in combination with pembrolizumab (pembro) in patients (pts) with HER2-expressing advanced solid tumors
    Meeting Abstract

    Sharma, M. R.; Carvajal, R. D.; Catenacci, D.; Emens, L. A.; Hanna, G. J.; Juric, D.; Kang, Y. K.; Lee, J.; Lee, K. W.; Li, B. T.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • A standard operating procedure for the curation of gene fusions
    Meeting Abstract

    Wagner, A. H.; Vlachos, I. S.; Sonkin, D.; Terraf, P.; Kesserwan, C.; Sboner, A.; Coard, T.; Reich, C.; Ritter, D. I.; Horak, P.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase 3 randomized trial comparing tebentafusp with investigator's choice in first line metastatic uveal melanoma
    Meeting Abstract

    Piperno-Neumann, S.; Hassel, J. C.; Rutkowski, P.; Baurain, J. F.; Butler, M. O.; Schlaak, M.; Sullivan, R. J.; Ochsenreither, S.; Dummer, R.; Kirkwood, J. M.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • IMmotion151: Updated overall survival (OS) and exploratory analysis of the association of gene expression and clinical outcomes with atezolizumab plus bevacizumab vs sunitinib in patients with locally advanced or metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Rini, B. I.; Atkins, M. B.; Escudier, B.; Powles, T.; McDermott, D. F.; Alekseev, B. Y.; Lee, J. L.; Stroyakovskiy, D.; Suarez Rodriguez, C.; De Giorgi, U.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Large-scale genome-wide association study identifies multiple novel germline susceptibility variants associated with bladder cancer risk
    Meeting Abstract

    Koutros, S.; Kiemeney, L. A.; Milne, R. L.; Ye, Y.; Joseph, V.; Figueroa, J.; Chatterjee, N.; Giles, G. G.; Hildebrandt, M. A.; Dyrskjot, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Pooled analysis of drug-related interstitial lung disease (ILD) in 8 single-arm trastuzumab deruxtecan (T-DXd) studies
    Meeting Abstract

    Powell, C. A.; Modi, S.; Iwata, H.; Takahashi, S.; Smit, E. F.; Siena, S.; Chang, D. Y.; Fuchs, C. S.; Nie, K.; Qin, A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers
    Meeting Abstract

    Subbiah, V.; Konda, B.; Bauer, T.; McCoach, C.; Falchook, G.; Takeda, M.; Patel, J.; Weiss, J.; Peled, N.; Bazhenova, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: